These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15174713)

  • 1. [Approaches in clinical management of metabolic syndrome. 2. Keypoints in testing for lipid metabolism anomalies and cardiovascular risk].
    Kugiyama K
    Nihon Naika Gakkai Zasshi; 2004 Apr; 93(4):683-9. PubMed ID: 15174713
    [No Abstract]   [Full Text] [Related]  

  • 2. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.
    Bestermann W; Houston MC; Basile J; Egan B; Ferrario CM; Lackland D; Hawkins RG; Reed J; Rogers P; Wise D; Moore MA
    Am J Med Sci; 2005 Jun; 329(6):292-305. PubMed ID: 15958871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Therapeutic Approaches in the Management of Cardiometabolic Diseases: Bringing the Concepts Together.
    Ren J; Zhang Y
    Curr Drug Targets; 2018; 19(9):987-988. PubMed ID: 29972102
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor's clothes fit?
    Reaven GM
    Diabetes Care; 2004 Apr; 27(4):1011-2. PubMed ID: 15047666
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperlipidaemia and cardiovascular disease: cardiovascular disease and the metabolic syndrome: further research or more implementation?
    Hanna FW
    Curr Opin Lipidol; 2002 Dec; 13(6):697-9. PubMed ID: 12441895
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic syndrome: cardiovascular risk assessment and management.
    Wong ND
    Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.
    Grundy SM; Hansen B; Smith SC; Cleeman JI; Kahn RA; ; ;
    Circulation; 2004 Feb; 109(4):551-6. PubMed ID: 14757684
    [No Abstract]   [Full Text] [Related]  

  • 8. Myths and facts...about cardiovascular dysmetabolic syndrome.
    Munson BL
    Nursing; 2003 Jul; 33(7):74. PubMed ID: 12862024
    [No Abstract]   [Full Text] [Related]  

  • 9. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Bozkurt B; Aguilar D; Deswal A; Dunbar SB; Francis GS; Horwich T; Jessup M; Kosiborod M; Pritchett AM; Ramasubbu K; Rosendorff C; Yancy C;
    Circulation; 2016 Dec; 134(23):e535-e578. PubMed ID: 27799274
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic syndrome.
    Dominiczak MH
    Curr Opin Lipidol; 2003 Jun; 14(3):329-32. PubMed ID: 12840663
    [No Abstract]   [Full Text] [Related]  

  • 11. Second World Congress on the Insulin Resistance Syndrome: hypertension, cardiovascular disease, and treatment approaches.
    Bloomgarden ZT
    Diabetes Care; 2005 Aug; 28(8):2073-80. PubMed ID: 16043765
    [No Abstract]   [Full Text] [Related]  

  • 12. Point: the metabolic syndrome still lives.
    Grundy SM
    Clin Chem; 2005 Aug; 51(8):1352-4. PubMed ID: 16040840
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic syndrome: a marker of patients at high cardiovascular risk.
    Lau DC; Yan H; Dhillon B
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):85B-90B. PubMed ID: 16498518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.
    Houston MC; Basile J; Bestermann WH; Egan B; Lackland D; Hawkins RG; Moore MA; Reed J; Rogers P; Wise D; Ferrario CM
    Am J Med Sci; 2005 Jun; 329(6):276-91. PubMed ID: 15958870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to cardiovascular disease and its treatment.
    Bloomgarden ZT
    Diabetes Care; 2003 Dec; 26(12):3342-8. PubMed ID: 14633826
    [No Abstract]   [Full Text] [Related]  

  • 16. The prevention and treatment of metabolic syndrome and high-risk obesity.
    Molavi B; Rasouli N; Kern PA
    Curr Opin Cardiol; 2006 Sep; 21(5):479-85. PubMed ID: 16900012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia.
    Liao Y; Kwon S; Shaughnessy S; Wallace P; Hutto A; Jenkins AJ; Klein RL; Garvey WT
    Diabetes Care; 2004 Apr; 27(4):978-83. PubMed ID: 15047659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing CVD risk.
    Aranjo C
    Aust Fam Physician; 2008 Sep; 37(9):695. PubMed ID: 18837159
    [No Abstract]   [Full Text] [Related]  

  • 19. Dysmetabolic syndrome: multiple risk factors for premature adult disease in an adolescent girl.
    Falkner B; Hassink S; Ross J; Gidding S
    Pediatrics; 2002 Jul; 110(1 Pt 1):e14. PubMed ID: 12093995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intervention with rumba and nutrition education to modify cardiovascular risk factors in adults with metabolic syndrome].
    Pérez-Idárraga A; Valencia Gómez K; Gallo Villegas J; Arenas Sosa M; Quintero Velásquez MA
    Rev Panam Salud Publica; 2015 Jan; 37(1):29-37. PubMed ID: 25791185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.